| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) ▼ | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2434 | CK iso-enzymen | Serum |
1× per maand | 969 (40,4) | – | 14680-3 U/l | – | › | ||
| 23234 | MAR-test serum Anti-spermatozoïden antistoffen, MAR-indirect | Serum |
1× per 3 weken | 952 (39,7) | – | 10617-9 % | – | › | ||
| 2592 | anti-IA2 antilichamen | Serum |
1× per maand | 909 (37,9) | – | 31209-0 U/mL | – | › | ||
| 3242 | anti-MAG As Myeline geassocieerde glycoproteïne antistoffen | Serum |
873 (36,4) | – | 31023-5 | – | › | |||
| 8241 | Para-aminofenol p-aminofenol | Urine |
755 (31,5) | – | – mg/l | – | › | |||
| 1449 | Mucoviscidose CF, CFTR, Cystic Fibrosis Transmembrane conductance Regulator-gen | EDTA |
724 (30,1) | – | – | – | › | |||
| 3258 | anti-ganglioside AS | Serum |
667 (27,8) | – | 82455-7 | – | › | |||
| 2902 | Complement C2 | Serum |
1× per 2 weken | 663 (27,6) | – | 4484-2 mg/l | – | › | ||
| 4383 | Pneumokokken polysach.AS | Serum |
1× per week | 636 (26,5) | – | 25531-5 | – | › | ||
| 7775 | Mevalonzuur Mevalonaat | Urine |
1× per maand | 550 (22,9) | – | – mmol/mol creat. | – | › | ||
| 4718 | Rabies-serologie Hondsdolheid antistoffen | Serum |
544 (22,7) | – | – IU/ml | – | › | |||
| 5022 | Inhibine A | Serum |
1× per maand | 527 (21,9) | – | 23883-2 ng/L | – | › | ||
| 3538 | IgE t201 Sparrenboom t201 Picea abies IgE | Serum |
525 (21,9) | – | 6857-7 kU/l | – | › | |||
| 1274 | Factor VII dosage Proconvertine | Citraat |
1× per 2 weken | 521 (21,7) | – | 3198-9 % | – | › | ||
| 4913 | Cyfra 21-1 | Serum |
480 (20) | – | 25390-6 ug/L | – | › | |||
| 1684 | Pyruvaatkinase in RBC Pyruvaatkinase intraerythrocytair | EDTA |
459 (19,1) | – | 32552-2 U/g Hb | – | › | |||
| 1683 | JAK2 V617F mutatie JAK2 mutatie, JAK2 mutation | EDTA |
1× per week | 424 (17,7) | – | – | – | › | ||
| 1292 | Factor XI dosage | Citraat |
1× per 2 weken | 422 (17,6) | – | 3226-8 % | – | › | ||
| 3316 | anti-VGCC (Ca kanaal As) | Serum |
412 (17,2) | – | 31024-3 pmol/L | – | › | |||
| 7039 | Organische zuren | Urine |
1× per 3–4 weken | 412 (17,2) | – | 33477-1 | – | › | ||
| ● 25242 | Antidiuretisch hormoon ADH, Vasopressine | EDTA |
1× per 2 weken | 398 (16,6) | – | 3126-0 pg/ml | 3126-0 ng/l | › | ||
| 56292 | Trichloorethyleen | Heparine (Lithium-heparinebuis) |
1× per week | 393 (16,4) | – | 74682-6 µg/dL | – | › | ||
| 8298 | Antidepress.opsporen/id. | Urine |
381 (15,9) | – | 19312-8 | – | › | |||
| 4336 | Leishmania antistoffen | Serum |
1× per week | 378 (15,8) | – | 7958-2 | – | › | ||
| 4308 | E.histolytica (ELISA) Amoebiase | Serum |
2× per week | 358 (14,9) | – | 90297-3 Ratio | – | › | ||
| 57152 | 17-hydroxyprogest. 60 min 17-OH progesteron 60min. | Serum |
3× per week | 357 (14,9) | B | 101312-7 ng/dl | 55469-1 nmol/l | › | ||
| 3837 | IgE m7 Botrytis cinerea | Serum |
355 (14,8) | – | 6049-1 kU/l | – | › | |||
| 55851 | Fluvoxamine Fevarin, Floxyfral | Serum |
1× per week | 354 (14,8) | – | 10988-4 ng/ml | 32073-9 nmol/L | › | ||
| 3284 | Lp-PLA2 Lipoprotein-associated Phospholipase A2, PLAC-test | Serum |
tenminste 1× per week | 351 (14,6) | – | – nmol/min/mL | – | › | ||
| 56320 | Methanol | Heparine (Lithium-heparinebuis) |
1× per week | 335 (13,9) | – | 9334-4 mg/l | – mmol/L | › | ||
| 5623 | Vedolizumab | Serum |
1× per 1–2 weken | 332 (13,8) | – | – µg/mL | – | › | ||
| 21707 | Pregnenolone | Serum |
1× per 2 weken | 328 (13,7) | – | 2837-3 µg/L | – | › | ||
| 4310 | Ascaris As. | Serum |
1× per 2 weken | 327 (13,6) | – | 26671-8 | – | › | ||
| 3306 | anti-glycine receptor As | Serum |
319 (13,3) | – | 95722-5 | – | › | |||
| 56154 | Chroom (volbloed) Cr | Oligo-elementen (spoorelementen) |
tenminste 2× per week | 318 (13,3) | B | 5619-2 µg/l | 15118-3 nmol/L | › | ||
| 56200 | Kobalt (volbloed) Co | Oligo-elementen (spoorelementen) |
tenminste 2× per week | 318 (13,3) | B | 5625-9 µg/l | 15119-1 nmol/L | › | ||
| 4484 | anti Delta As Hepatitis D virus As | Serum |
312 (13) | – | 95141-8 | – | › | |||
| 5230 | Glucagon | EDTA |
1× per 2 weken | 311 (13) | – | 2338-2 pg/ml | – | › | ||
| 52752 | Caroteen (beta-fractie) | Serum |
1× per week | 310 (12,9) | – | 2053-7 µg/dL | 14642-3 µmol/L | › | ||
| 23220 | Acetylcholinereceptor As | Serum |
1× per 1–2 weken | 308 (12,8) | – | 20427-1 nmol/l | – | › | ||
| 2655 | alfa Galactosidase | EDTA |
1× per week | 308 (12,9) | – | 1813-5 µmol/L/h | – | › | ||
| 57151 | 17-hydroxyprogest. 30min 17-OH progesteron 30min. | Serum |
3× per week | 304 (12,7) | B | 101311-9 ng/dl | 55470-9 nmol/l | › | ||
| 2642 | Aminozuren kwantitatief | Heparine (Lithium-heparinebuis) |
2× per week | 303 (12,6) | – | 1913-3 | 35083-5 | › | ||
| 4306 | Ech.multilocularis(ELISA) | Serum |
295 (12,3) | – | – Ratio | – | › | |||
| 3827 | IgE f313 Ansjovis | Serum |
292 (12,2) | – | 7079-7 kU/l | – | › | |||
| 5978 | Amikacine Dal Amukin | Serum |
291 (12,1) | – | 3321-7 mg/l | – µmol/L | › | |||
| 5921 | Olanzapine Zalasta, Zyprexa | Serum |
1× per week, op donderdag | 283 (11,8) | – | 12389-3 µg/L | – | › | ||
| 3277 | anti-MuSK As Anti-muscle specific kinase antistoffen | Serum |
278 (11,6) | – | 94273-0 | – | › | |||
| 5094 | Osteocalcine Gla | EDTA |
274 (11,4) | – | 2697-1 ng/mL | – | › | |||
| 23222 | Bijnier (1/10) | Serum |
in batch, zodra er voldoende aanvragen zijn | 272 (11,3) | – | 57745-2 | – | › |
